Cite
HARVARD Citation
Barone, M. et al. (2019). Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. British journal of haematology. pp. 987-991. [Online].